FOLH1 and pachyonychia congenita: For the 68Ga-PSMA cohort, the distribution of the PSMA-avid PC lesions in the prostate was as follows: 31.4% (11/35) with GS ≤ 7a vs. 68.6% (24/35) with GS ≥ 7b, respectively (Figure 2).